US EditionRelated Stocks: MDT, …
Summary by Stockxpo - A Professional Network of Traders, Investors and Analysts
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Related Stocks: MDT, …
FDA grants approval for Medtronic’s (MDT, Financial) new Simplera Sync sensor for MiniMed 780G system. New sensor promises no fingerstick requirement and simplified insertion process. U.S. launch set for fall 2025. Medtronic (MDT) has received U.S. FDA approval for its latest innovation, the Simplera Sync sensor, tailored for use with the MiniMed 780G system. This new addition to Medtronic’s continuous glucose monitoring (CGM) portfolio is a dis…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
